ZSCAN18 and neoplasm: To gain insights into the molecular mechanisms underlying the tumor inhibition of ZSCAN18, we analyzed the downstream signaling pathways modulated by ZSCAN18 through RNA next-generation sequencing (RNA-seq) in ZSCAN18-overexpressed and control NCI-N87 cells.